Advisory Board and Editors Drugs & Devices
Hidekazu Hiroaki
Dr. Hidekazu Hiroaki is Professor within the Graduate School of Pharmaceutical Sciences, Nagoya University, Japan. He received his PhD in Pharmaceutical Sciences (PhD thesis "Spectroscopic study for interaction between DNA oligonucleotide and bleomycin”) from the Graduate School of Osaka University, Japan in 1992.
Dr Hiroaki's research focuses on the structural biology of proteins by using solution NMR techniques, including protein-protein and protein-drug interaction. He is also focusing on NMR-assisted in silico drug discovery as well as protein structure determination. He is also an expert of intrinsically disordered proteins and some disease related amyloid genic proteins.
Professional experience:
2012-present: Professor, Graduate School of Pharmaceutical Sciences, Nagoya University (Nagoya, Aichi, Japan)
2011-2012: Professor, Research Center for Structural Biology, Department of Science, Nagoya University (Nagoya, Aichi, Japan)
2007-2011: Professor, Division of Structural Biology, Graduate School of Medicine, Kobe University, (Kobe, Hyogo, Japan)
2001-2007: Associate Professor, International Graduate School of Art and Science, Yokohama City University, (Kanagawa, Japan)
1995-2001: Research Scientist, Division of Structural Biology, Biomolecular Engineering Research Institute (BERI) (Suita, Osaka, Japan)
1994-1995: Visiting Scientist, Research Centre, F Hoffman La Roche (Basel, Switzerland)
1992-1994: Research Scientist, Department of Molecular Genetics, Nippon Roche Research Center (Kanagawa, Japan)
Bill Hooker
PhD = cloning and characterizing potential vaccine antigens from schistosomes; first postdoc = fine details of HIV replication (with David Harrich); second postdoc = best ignored; third postdoc = role of Max network, especially Mnt, in cancer and development (with Peter Hurlin). After that I made HIV POC tests and other diagnostic devices in two small biotech companies. Now I'm a research manager with Canon US Life Sci.
Victor J. Hruby
Regents Professor of Chemistry and Biochemistry at the University of Arizona. Professor of Neuroscience recently inducted into the ACS Hall of Fame and 2011 ACS Goodman Award for Scientific Excellence and Mentorship.
Zunnan Huang
Professor in Chemistry; Director, Key Laboratory of Big Data Mining and Precision Drug Design; Director, Key Laboratory of Computer-Aided Drug Design of Dongguan City; Vice Dean, Graduate School of Guangdong Medical University; PhD in Computational Chemistry and Physical Chemistry obtained from the University of Oklahoma; Guest Editor, Current Pharmaceutical Design, Current Medicinal Chemistry, Frontiers in Chemistry, Molecules; Reviewer for more than 50 SCI journals including Journal of the American Chemical Society, Science Advances, Nature Communications and Briefings in Bioinformatics. Authors of more than 117 SCI papers with an accumulated IF of 600.
Łukasz Jaremko
Dr. Łukasz Jaremko is Associate Professor at King Abdullah University of Science and Technology.
Research in Dr. Jaremko's Molecular Diagnostics and Drug Discovery (MD3) group focuses on atomic-level insight into essential and topical questions from biochemistry and medicine.
Kazunori Kataoka
Professor of Biomaterials at Department of Materials Engineering of University of Tokyo. Joint appointment in Medical School of University of Tokyo as Professor of Clinical Biotechnology, Center for Disease Biology and Integrative Medicine. Editorial of Journal of Biomaterials Science, Polymer Edition. Associate Editor of Biomacromolecules. Associate Editor of Biomaterials. Recipient of the 2012 Humboldt Research Award. President of Controlled Release Society. Reciepient of the 2015 Journal of Drug Targeting Life-Time Achievement Award.
Alex Kentsis
Assistant Professor of Pediatrics at the Memorial Sloan Kettering Cancer Center and Weill Cornell Medical College of Cornell University.
He leads research in the functional proteomics and genomic plasticity of refractory childhood cancers.
Kam W. F. Leong
James B. Duke Professor of Biomedical Engineering at Duke University. Recipient of the 2012 Clemson Award for Applied Research.
Maria Paula M Marques
Maria Paula Marques (October 1960, Portugal) received her MSc in Physical-Chemistry (1987), her PhD (1995) and her habillitation (2018) from the University of Coimbra (Portugal). M.P.M. Marques is currently an assistant professor at the Department of Life Sciences of the University of Coimbra, assistant-coordinator of the R&D Group “Molecular Physical-Chemistry” and head of the “Chemoprevention, -Therapy & -Toxicology” laboratory. M.P.M. Marques has authored 140 scientific papers, 8 book chapters and co-edited 3 books. She is a fellow of the Royal Society of Chemistry and a member of the Clinical Infrared and Raman Spectroscopy for Medical Diagnosis (CLIRSPEC), the portuguese delegate for the COST Action Raman4Clinics, an associate editor of RSC Advances and a member of the editorial board of Recent Patents on Anti-Cancer Drug Discovery.
Her research is centred on the development of metal-based antitumour agents and on the early diagnostics of cancer, using vibrational spectroscopy, including neutron techniques and synchrotron-based methods.
KoonGee Neoh
Professor of Chemical Engineering at the National University of Singapore. Recipient of the 1996 National Science Award of Singapore.
Marisa Fabiana Nicolás
Dr. Marisa Fabiana Nicolás is a biologist with a Ph.D. in Genetics. She worked as a protein annotator in the UniProt/Swiss-Prot database from 2005 to 2007. Since May 2009 she is an Associate Researcher at the Bioinformatics Laboratory (Labinfo) at LNCC/MCTI Brazil. Dr. Nicolas has experience in Genetics, Molecular Biology, Genomics, and Bioinformatics. She works mainly in Bioinformatics applied to the analysis of genomes and transcriptomes (RNAseq and scRNAseq) and metabolic and regulatory networks in clinically relevant pathogens.
Audrey R Odom John
Chief, Division of Infectious Diseases, Children's Hospital of Philadelphia
The primary research goals of our lab are to understand the biological functions of specific metabolic pathways in the malaria parasite--that is, to understand what the parasite needs to make, and why it needs to make it.